Journal of Clinical Lipidology·7 OctEfficacy and tolerability of targeted lipoprotein(a)-lowering therapies: A systematic reviewSystematic reviewInterventionsPaper
Clinical Research in Cardiology·3 SepBody composition phenotypes are key predictors of cardiovascular-kidney-metabolic multimorbidity and long-term mortality: insights from a population-based cohort studyCohort study in peopleCardiovascular-kidney-metabolic syndromePaper
EClinicalMedicine·30 AugThe global cardiovascular-kidney-liver-metabolic burden from 1990 to 2023Computational studyAtherosclerotic cardiovascular diseasePaper
JACC Asia·19 AugSouth Asian Cardiovascular Risk: Role of Coronary Artery Calcium Scoring and Computed Tomography AngiographyReviewAtherosclerotic cardiovascular diseasePaper
European Journal of Preventive Cardiology·4 AugThe role of lipoprotein (a) in premature cardiovascular disease: primed for preventionReviewLipoproteinPaper
AHA Scientific Sessions 2025 Abstract·3 NovEvaluation of the PREVENT Risk Assessment Tool and Visceral Adiposity: Insights from the UK BiobankStudy in peopleBiomarkersPaper
AHA Scientific Sessions 2025 Abstract·3 NovElevated Lipoprotein(a) Is Independently Associated With Greater Infarct Size, Especially in Premature AtherosclerosisStudy in peopleBiomarkersPaper